Edited sentence: ), it was not surprising then that the knives of scrutiny and skepticism were already being sharpened against cisatracurium in the court of peer-reviewed publications even before the voluminous documentation necessary for impartial review and approval of the drug had barely been dispatched to the desks at the US Food and Drug Administration., Organon Inc.Owing to the intense marketing rivalry, during the 1980s and 1990s, between the two major competitors at the time in this area of anesthesia (i.and Burroughs Wellcome, Co